FDA approves first new sunscreen ingredient in 25 years
FDA approves first new sunscreen ingredient in 25 years
FDA approves first new sunscreen ingredient in 25 years
The U.S. Food and Drug Administration (FDA) has approved bemotrizinol, a new sunscreen ingredient, after a 25-year wait. This marks the first time the agency has used a faster review process introduced by Congress in 2020. Health officials say the move will boost innovation and improve consumer trust in sun protection products. Bemotrizinol has been safely used in Europe for decades. It protects against both UVA and UVB rays without leaving a white residue on the skin. Experts note that it causes minimal irritation and is absorbed less than many other sunscreen ingredients.
The FDA’s approval allows DSM Nutritional Products to sell bemotrizinol under the brand name Parsol Shield. After an 18-month exclusivity period, other manufacturers will also be able to use the ingredient. The product is considered safe for adults and children aged six months and older. Health and Human Services Secretary Robert F. Kennedy praised the decision. He said it would encourage further advancements in sunscreen technology. The FDA has been updating its sunscreen regulations in recent years, including banning misleading labels and requiring broader UV protection.
The approval of bemotrizinol introduces a long-awaited option for U.S. consumers. It offers strong sun protection without common drawbacks like skin irritation or white streaks. The decision also sets a precedent for faster reviews of future sunscreen ingredients.